The value of 18F-FDG PET/CT in recurrent gynecologic malignancies prior to pelvic exenteration

Gynecologic Oncology

Volumn 129, Issue 3, 2013, Pages 586-592

  Burger, Irene A ^a   Vargas, Hebert Alberto ^a   Donati, Olivio F ^a   Andikyan, Vaagn ^a   Sala, Evis ^a   Gonen, Mithat ^a   Goldman, Debra A ^a   Chi, Dennis S ^a   Schöder, Heiko ^a   Hricak, Hedvig ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cancer recurrence; Cervical cancer; Endometrial cancer; Pelvic exenteration; PET; Total lesion glycolysis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BLADDER; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GYNECOLOGIC CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LYMPH NODE METASTASIS; OVERALL SURVIVAL; PELVIS EXENTERATION; PET SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECTUM; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR INVASION; TUMOR VOLUME; UTERINE CERVIX CANCER; UTERUS CANCER; VAGINA CANCER; VULVA CANCER; DISEASE FREE SURVIVAL; FEMALE GENITAL TRACT TUMOR; LYMPH NODE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING; SURVIVAL RATE; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; GENITAL NEOPLASMS, FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PELVIC EXENTERATION; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

MLCS; MLOWN;

EID: 84877575419     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.01.017     Document Type: Article

References (21)

1. M.J. Lopez, and L. Barrios Evolution of pelvic exenteration Surg Oncol Clin N Am 14 2005 587 606
2. A. Brunschwig Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy Cancer 1 1948 177 183
3. A.M. Schmidt, P. Imesch, D. Fink, and H. Egger Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer Gynecol Oncol 125 2012 604 609
4. J.Y. Park, H.J. Choi, S.Y. Jeong, J. Chung, J.K. Park, and S.Y. Park The role of pelvic exenteration and reconstruction for treatment of advanced or recurrent gynecologic malignancies: analysis of risk factors predicting recurrence and survival J Surg Oncol 96 2007 560 568
5. F. Khoury-Collado, M.H. Einstein, B.H. Bochner, K.M. Alektiar, Y. Sonoda, and N.R. Abu-Rustum Pelvic exenteration with curative intent for recurrent uterine malignancies Gynecol Oncol 124 2012 42 47
6. J.S. Berek, C. Howe, L.D. Lagasse, and N.F. Hacker Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA Gynecol Oncol 99 2005 153 159
7. V. Andikyan, F. Khoury-Collado, S.R. Gerst, S. Talukdar, B.H. Bochner, and J.S. Sandhu Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome Gynecol Oncol 126 2012 346 350
8. M.J. Popovich, H. Hricak, K. Sugimura, and J.L. Stern The role of MR imaging in determining surgical eligibility for pelvic exenteration AJR Am J Roentgenol 160 1993 525 531
9. R.C. Dresen, M. Kusters, A.W. Daniels-Gooszen, V.C. Cappendijk, G.A. Nieuwenhuijzen, and A.G. Kessels Absence of tumor invasion into pelvic structures in locally recurrent rectal cancer: prediction with preoperative MR imaging Radiology 256 2010 143 150
10. A. Husain, T. Akhurst, S. Larson, K. Alektiar, R.R. Barakat, and D.S. Chi A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration Gynecol Oncol 106 2007 177 180
11. L.J. Havrilesky, S.L. Kulasingam, D.B. Matchar, and E.R. Myers FDG-PET for management of cervical and ovarian cancer Gynecol Oncol 97 2005 183 191
12. E.A. Kidd, B.A. Siegel, F. Dehdashti, and P.W. Grigsby The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival Cancer 110 2007 1738 1744
13. E.A. Kidd, B.A. Siegel, F. Dehdashti, and P.W. Grigsby Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer Cancer 116 2010 1469 1475
14. F.Y. Liu, A. Chao, C.H. Lai, H.H. Chou, and T.C. Yen Metabolic tumor volume by (18)F-FDG PET/CT is prognostic for stage IVB endometrial carcinoma Gynecol Oncol 125 2012 566 571
15. Y.E. Erdi Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding Cancer 80 1997 2505 2509
16. J.R. Landis, and G.G. Koch Measurement of observer agreement for categorical data Biometrics 33 1977 159 174
17. F. Xue, L.L. Lin, F. Dehdashti, T.R. Miller, B.A. Siegel, and P.W. Grigsby F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy Gynecol Oncol 101 2006 147 151
18. H.H. Chung, J.W. Kim, K.H. Han, J.S. Eo, K.W. Kang, and N.H. Park Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer Gynecol Oncol 120 2011 270 274
19. S.M. Larson, Y. Erdi, T. Akhurst, M. Mazumdar, H.A. Macapinlac, and R.D. Finn Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis Clin Positron Imaging 2 1999 159 171
20. H. Hricak, B.I. Choi, A.M. Scott, K. Sugimura, A. Muellner, and G.K. von Schulthess Global trends in hybrid imaging Radiology 257 2010 498 506
21. D. Delbeke SNM/ABNM joint position statement on optimizing training in nuclear medicine in the era of hybrid imaging J Nucl Med 2012 [1978]